Falsified and substandard medicine harms patients, potentially causing disease progression, adverse events, and even death. When patients buy medicine from an illegal online pharmacy, these negative outcomes are definite possibilities. In today’s post-pandemic era, when consumers shop online for everything including medicine, it is critical for patients to understand the risks associated with illegal online […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) and eight other health care organizations have released a joint position statement encouraging racial diversity, equity, and inclusion (DEI) in all areas of health care, including regulatory boards, the workforce, education, and patient care. Ensuring DEI among health care leadership is key to enhancing professional opportunities and health […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) has released a policy statement detailing its support of current efforts to improve pharmacist workplace safety and well-being. The issues of pharmacist workload, burnout, and well-being, and their effect on patient safety, have been considered for years, but the coronavirus disease 2019 pandemic has brought concerns related to […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) proudly announces its continued confidence in the safety of the coronavirus disease 2019 (COVID-19) vaccines approved for emergency use authorization by Food and Drug Administration. The authorized vaccines have followed a strict testing and approval process throughout all stages of vaccine development. “We can have greater control over […]

Read More ›

The recent deaths of George Floyd, Breonna Taylor, Ahmaud Arbery, and too many others have ignited strong emotions and continue to shed a glaring light on the day-to-day experiences of Black Americans. Sadly, racism and discrimination are a thread that has been woven into the fabric of this country for far too long. Adding to […]

Read More ›

Prescription Drug Importation is Not a Viable Solution to High Prescription Drug Costs Policymakers, rightfully so, have sought to lower prescription drug costs for ordinary Americans. Some of the proposals being considered would allow for importation of prescription drugs from other countries where they are currently being sold at cheaper prices. These proposals have ranged […]

Read More ›

The National Conference of Pharmaceutical Organizations (NCPO) is a coalition of organizations and associations that represents the discovery, manufacture, and distribution of medications and practitioners that provide effective patient care. Collectively, our organizations represent over 300,000 individual pharmacy practitioners and pharmaceutical scientists, companies engaged in diverse aspects of healthcare delivery, and the nation’s pharmacy regulators […]

Read More ›

The Tri-Regulator Collaborative, the governing boards of the three organizations representing the state boards that license physicians, nurses, and pharmacists – the Federation of State Medical Boards (FSMB), National Association of Boards of Pharmacy (NABP), and National Council of State Boards of Nursing (NCSBN) – have drafted and approved two position statements that highlight the […]

Read More ›

As the opioid overdose epidemic continues to take hundreds of lives each week, the National Association of Boards of Pharmacy® (NABP®) has issued a policy statement promoting an active role for pharmacists in expanding access to the opioid overdose reversal drug, naloxone. Nearly 17,000 people died from an overdose involving an opioid analgesic in 2011, four […]

Read More ›

As the organizations representing the state and territorial licensing boards in the United States that regulate the practice of medicine, pharmacy and nursing, the Federation of State Medical Boards (FSMB), National Association of Boards of Pharmacy (NABP), and National Council of State Boards of Nursing (NCSBN) affirm that in a consumer protection model, health care […]

Read More ›